Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling].

Giornale italiano di cardiologia (2006) - 1 Mar 2016

Coppini Raffaele, Ferrantini Cecilia, Poggesi Corrado, Mugelli Alessandro, Olivotto Iacopo

Abstract excerpt

Myocardial hypertrophic remodeling is a pathophysiological feature of several cardiac conditions and is the hallmark of hypertrophic cardiomyopathy (HCM), the most common monogenic inherited disease of the heart. In recent years, preclinical and clinical studies investigated the underlying molecular mechanisms and intracellular signaling pathways involved in pathologic cardiomyocyte hypertrophy and highlighted a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium Channel Blockers
Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Agents

Share to Evidence-Based Medicine

Share to Feasibility Studies

Share to Heart Valve Diseases

Share to Myocytes, Cardiac

Share to Ventricular Remodeling

Source

Identifiers

PMID: 27029877
DOI: 10.1714/2190.23660

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling].PMID 27029877Read ↗

Cardiac Hypertrophy: Mechanisms and Therapeutic OpportunitiesSemantic proximity Read ↗

Novel molecular insights and potential approaches for targeting hypertrophic cardiomyopathy: Focus on coronary modulators.Semantic proximity Read ↗

Preventative therapeutic approaches for hypertrophic cardiomyopathy.Semantic proximity Read ↗

Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives.Semantic proximity Read ↗

Hypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipeline.Semantic proximity Read ↗

[Hypertrophic cardiomyopathy: current aspects and new developments].Semantic proximity Read ↗

Hypertrophic cardiomyopathy: current understanding and treatment objectives.Semantic proximity Read ↗

Hypertrophic cardiomyopathy.Semantic proximity Read ↗

Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.Semantic proximity Read ↗

Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy.Semantic proximity Read ↗

Theranostic biomarkers in hypertrophic cardiomyopathy: insights in a long road ahead.Semantic proximity Read ↗

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.